Evidence map›Paper›PMID 37490006›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2023

Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes.

Stephanie A Eid, Phillipe D O'Brien, Katharina H Kretzler, Dae-Gyu Jang, Faye E Mendelson, John M Hayes, Andrew Carter, Hongyu Zhang, Subramaniam Pennathur, Frank C Brosius and 2 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. NONcNZO10/LtJ and TALLY-HO/JngJ Mice as Novel Models of Diabetic Peripheral Neuropathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Stephanie A EidDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0003-3775-7544
Phillipe D O'BrienDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-6365-3477
Katharina H KretzlerDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0003-3042-814X
Dae-Gyu JangDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0009-0009-7966-1322
Faye E MendelsonDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-5601-7675
John M HayesDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-5677-2216
Andrew CarterDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0009-0006-7953-8998
Hongyu ZhangDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Subramaniam PennathurDivision of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0003-3628-6883
Frank C BrosiusDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-4244-8335
Emily J KoubekDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0001-6952-3326
Eva L FeldmanDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-9162-2694
University of Michigan · USUniversity of Arizona · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Integrated Systems Biology Approach to Diabetic Microvascular ComplicationsR24DK082841 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABCOUWER, STEVEN F, BROSIUS, FRANK C · 2008 to 2020
$13.1M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
LIPID, LIPOPROTEIN, AND GLUCOSE METABOLISM COREU24DK059630 · NIDDK · UNIVERSITY OF CINCINNATI · PI TSO, PATRICK · 2001 to 2015
$12.9M
Michigan Mouse Metabolic Phenotyping CenterU2CDK110768 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELIAS, CAROL FUZETI · 2016 to 2021
$6.2M
Lipid profile, lipoprotein and apolipoprotein composition, and intestinal fat absorption efficiency in germ-free and conventional miceU2CDK059630 · NIDDK · UNIVERSITY OF CINCINNATI · PI LIU, MIN · 2016 to 2021
$4.9M
Schwann Cell Senescence and the Secretome Provide a Unifying Mechanism for the Onset and Progression of Diabetic NeuropathyR01DK130913 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eva Lucille Feldman, Junguk Hur · 2022 to 2026
$3.3M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK081943NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK130913NIDDK NIH HHS R24 DK082841NIDDK NIH HHS U24 DK059630NIDDK NIH HHS U2C DK059630NIDDK NIH HHS U2C DK110768
6 · The paper itself

Abstract

Patients with type 2 diabetes often develop the microvascular complications of diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN), which decrease quality of life and increase mortality. Unfortunately, treatment options for DKD and DPN are limited. Lifestyle interventions, such as changes to diet, have been proposed as non-pharmacological treatment options for preventing or improving DKD and DPN. However, there are no reported studies simultaneously evaluating the therapeutic efficacy of varying dietary interventions in a type 2 diabetes mouse model of both DKD and DPN. Therefore, we compared the efficacy of a 12-week regimen of three dietary interventions, low carbohydrate, caloric restriction, and alternate day fasting, for preventing complications in a db/db type 2 diabetes mouse model by performing metabolic, DKD, and DPN phenotyping. All three dietary interventions promoted weight loss, ameliorated glycemic status, and improved DKD, but did not impact percent fat mass and DPN. Multiple regression analysis identified a negative correlation between fat mass and motor nerve conduction velocity. Collectively, our data indicate that these three dietary interventions improved weight and glycemic status and alleviated DKD but not DPN. Moreover, diets that decrease fat mass may be a promising non-pharmacological approach to improve DPN in type 2 diabetes given the negative correlation between fat mass and motor nerve conduction velocity.

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesAnimalsCaloric RestrictionFastingMiceMice, Inbred StrainsQuality of Lifecaloric restrictiondb/db mouse modeldiabetic kidney diseasediabetic neuropathyintermittent fastinglow-carbohydrate diettype 2 diabetes

Identifiers

PMID37490006
PMCPMC10372884
OpenAlexW4385230089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.